Jazz Pharmaceuticals (JAZZ) Inventory Average (2011 - 2026)

Jazz Pharmaceuticals' Inventory Average history runs 16 years deep, the most recent figure standing at $427.2 million for Q1 2026.

• On a quarterly basis, Inventory Average fell 12.2% year-over-year to $427.2 million in Q1 2026; TTM through Mar 2026 was $427.2 million, a 12.2% decrease from a year earlier, with the FY2025 full-year figure at $448.7 million, down 16.71% from the prior year.
• Inventory Average slipped to $427.2 million in Q1 2026 per JAZZ's latest filing, from $450.1 million in the prior quarter.
• Across five years, Inventory Average topped out at $1.0 billion in Q1 2022 and bottomed at $427.2 million in Q1 2026.
• The 5-year median for Inventory Average is $587.2 million (2024), against an average of $624.9 million.
• Biggest YoY gain for Inventory Average was 876.04% in 2022; the steepest drop was 34.76% in 2022.
• Year by year, Inventory Average stood at $721.1 million in 2022, then slipped by 16.18% to $604.4 million in 2023, then slipped by 15.64% to $509.9 million in 2024, then decreased by 11.73% to $450.1 million in 2025, then dropped by 5.07% to $427.2 million in 2026.
• Per Business Quant, the three latest JAZZ Inventory Average figures stand at $427.2 million (Q1 2026), $450.1 million (Q4 2025), and $494.0 million (Q3 2025).